2020 - Fellow of the Royal Society of Canada Academy of Social Sciences
1934 - Fellow of the American Association for the Advancement of Science (AAAS)
Member of the Association of American Physicians
Internal medicine, Oncology, Cancer research, Childhood Acute Lymphoblastic Leukemia and Acute lymphocytic leukemia are his primary areas of study. His Immunology research extends to Internal medicine, which is thematically connected. His work deals with themes such as Methotrexate, Clinical trial, Multivariate analysis, Asparaginase and Prednisone, which intersect with Oncology.
His research integrates issues of Gene rearrangement, Genome-wide association study, Gene expression profiling, Mutation and Tyrosine kinase in his study of Cancer research. His work carried out in the field of Childhood Acute Lymphoblastic Leukemia brings together such families of science as Mercaptopurine, Disease and Acute leukemia. His Acute lymphocytic leukemia study which covers Cancer that intersects with Precision medicine, Family medicine, Pathology and Alternative medicine.
William L. Carroll focuses on Internal medicine, Oncology, Acute lymphocytic leukemia, Leukemia and Cancer research. His Internal medicine study often links to related topics such as Cog. The study incorporates disciplines such as Cancer, Methotrexate, Immunology, Childhood Acute Lymphoblastic Leukemia and Prednisone in addition to Oncology.
His Immunology research includes themes of Allele and Drug resistance. His Acute lymphocytic leukemia research incorporates themes from Gene expression profiling, Regimen, Vincristine, Hematology and Single-nucleotide polymorphism. His studies examine the connections between Cancer research and genetics, as well as such issues in Mutation, with regards to Molecular biology.
William L. Carroll mainly investigates Internal medicine, Oncology, Leukemia, Lymphoblastic Leukemia and Cog. His work in Minimal residual disease, Methotrexate, Young adult, Acute lymphocytic leukemia and Clinical trial is related to Internal medicine. The Acute lymphocytic leukemia study which covers Vincristine that intersects with Mercaptopurine.
William L. Carroll has included themes like Cancer, Childhood Acute Lymphoblastic Leukemia, Randomized controlled trial and Chemotherapy in his Oncology study. His research on Leukemia concerns the broader Immunology. His Lymphoblastic Leukemia study combines topics in areas such as Down syndrome and Pharmacology.
William L. Carroll spends much of his time researching Internal medicine, Oncology, Leukemia, Clinical trial and Cancer research. As part of his studies on Internal medicine, William L. Carroll frequently links adjacent subjects like Cog. His Oncology study combines topics from a wide range of disciplines, such as Survival rate, Young adult, Chemotherapy and Minimal residual disease.
His studies in Leukemia integrate themes in fields like Hematology, Gene, Germline and Drug resistance. He combines subjects such as Thiopurine methyltransferase, Hypodiploid Acute Lymphoblastic Leukemia, Incidence and Pediatrics with his study of Clinical trial. His research in Cancer research focuses on subjects like Mutation, which are connected to DNA mismatch repair.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Deletion of IKZF1 and prognosis in acute lymphoblastic leukemia.
Charles G Mullighan;Xiaoping Su;Jinghui Zhang;Ina Radtke.
The New England Journal of Medicine (2009)
Targetable Kinase-Activating Lesions in Ph-like Acute Lymphoblastic Leukemia
K. G. Roberts;Y. Li;D. Payne-Turner;R. C. Harvey.
The New England Journal of Medicine (2014)
Improved Survival for Children and Adolescents With Acute Lymphoblastic Leukemia Between 1990 and 2005: A Report From the Children's Oncology Group
Stephen P. Hunger;Xiaomin Lu;Meenakshi Devidas;Bruce M. Camitta.
Journal of Clinical Oncology (2012)
Biology, Risk Stratification, and Therapy of Pediatric Acute Leukemias: An Update
Ching Hon Pui;William L. Carroll;Soheil Meshinchi;Robert J. Arceci.
Journal of Clinical Oncology (2011)
Clinical Cancer Advances 2013: Annual Report on Progress Against Cancer From the American Society of Clinical Oncology
Jyoti D. Patel;Lada Krilov;Sylvia Adams;Carol Aghajanian.
Journal of Clinical Oncology (2010)
Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia and its relationship to other prognostic factors: a Children's Oncology Group study.
Michael J. Borowitz;Meenakshi Devidas;Stephen P. Hunger;W. Paul Bowman;W. Paul Bowman.
Blood (2008)
Improved Early Event-Free Survival With Imatinib in Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia: A Children's Oncology Group Study
Kirk R. Schultz;W. Paul Bowman;Alexander Aledo;William B. Slayton.
Journal of Clinical Oncology (2009)
Genetic Alterations Activating Kinase and Cytokine Receptor Signaling in High-Risk Acute Lymphoblastic Leukemia
Kathryn G. Roberts;Ryan D. Morin;Jinghui Zhang;Martin Hirst.
Cancer Cell (2012)
JAK mutations in high-risk childhood acute lymphoblastic leukemia.
Charles G. Mullighan;Jinghui Zhang;Richard C. Harvey;J. Racquel Collins-Underwood.
Proceedings of the National Academy of Sciences of the United States of America (2009)
Rearrangement of CRLF2 is associated with mutation of JAK kinases, alteration of IKZF1, Hispanic/Latino ethnicity, and a poor outcome in pediatric B-progenitor acute lymphoblastic leukemia
Richard C. Harvey;Richard C. Harvey;Charles G. Mullighan;I-Ming Chen;I-Ming Chen;Walker Wharton.
Blood (2010)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
University of Pennsylvania
St. Jude Children's Research Hospital
The University of Texas Southwestern Medical Center
University of California, San Francisco
University of New Mexico
Johns Hopkins University
The Ohio State University
University of Washington
St. Jude Children's Research Hospital
University of Alabama at Birmingham
University of Maryland, College Park
Shenzhen Institutes of Advanced Technology
Fudan University
Bordeaux INP
University of Perugia
British Trust for Ornithology
University of Delaware
Collège de France
Ghent University
University of Manchester
Swiss Federal Institute for Forest, Snow and Landscape Research
University of Western Ontario
University of Delaware
University of Angers
Mayo Clinic
University of Illinois at Urbana-Champaign